Nintedanib in combination with paclitaxel achieves total remission of tumors in 50 pe

[News]

The experimental drug nintedanib, combined with standard chemotherapy with paclitaxel, causes a total remission of tumours in 50% of patients suffering from early HER-2- negative breast cancer, the...

More... (http://www.medicalnewstoday.com/releases/282399.php)